A research team affiliated with UNIST has unveiled a novel approach to halt the progression of colorectal cancer by inducing irreversible cellular aging. Their findings demonstrate that suppressing a ...

Roche has appointed leading Australian cancer researcher Prof Mark Dawson to lead its pharma Research and Early Development (pRED) division from its recently opened unit in Basel, Switzerland.

Two separate laboratory breakthroughs have produced RNA molecules that can build copies of themselves or assemble functional structures without any help from proteins or DNA. These results offer the ...

Different DNA Structures Nucleate the Folding of Proteins to form specific complexes that modulate the readout of ...

A clinical-stage oncology company developing targeted therapies that exploit DNA damage response (DDR) vulnerabilities in ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced data presentations from its innovative HIV treatment and prevention ...

Sandra Choi reflects on creative leadership, comfort, craftsmanship, and how she reshaped Jimmy Choo by designing for how women actually live.

Gilead Sciences, Inc. today announced details of new clinical and real-world data from its innovative HIV treatment and ...

By FY25, RollsKing closed at ₹85 crore in gross revenue. A month before FY26 wrapped, the group crossed ₹100 crore.Rolling Fresh now accounts for roughly 20% of total revenue--nearly ₹20 crore on its ...